RMA News & Events

This video introduces you to the world-renowned, full service fertility center, its Reproductive Endocrinologists, Urologist, Complementary Care team and highly qualified staff.

Original Research from RMANJ has Broad-Reaching Implications for Improving Success in IVF

Research Designated “Seminal Contribution” in April Issue of Fertility & Sterility

A new study conducted by Reproductive Medicine Associates of New Jersey has shown that an optimized method of Comprehensive Chromosome Screening (CCS) is the first technology capable of accurate aneuploidy screening (abnormal number of chromosomes) of all 24 chromosomes in four hours.

Single Motherhood by Choice:
Informational Event & Support Session
Sunday, April 29, 2012
10am – 12pm

Lisa Schuman, LCSW, RMA of New York’s staff Psychotherapist, in partnership with Single Mothers by Choice, is holding an informational event and support session for women who are considering or have chosen single motherhood. The event is open to all women in all stages of their reproductive journey.

Dr. Lawrence Grunfeld, Infertility Specialist at RMA of New York, discusses Preimplantation Genetic Diagnosis and Screening. Preimplantation Genetic Diagnosis (PGD) is an advanced genetic technique that allows an individual embryo to be analyzed. PGD is a recommended procedure for patients who are affected by a genetic condition or are carriers of a genetic anomaly and are at risk of passing the anomaly on to their offspring. Preimplantation Genetic Screening (PGS), on the other hand, may be used when patients do not have a known genetic disorder, but are experiencing infertility related to recurrent miscarriage or unsuccessful IVF cycles. PGD technology used with in vitro fertilization (IVF) treatment can improve the likelihood of a successful and healthy pregnancy.

Dr. Natan Bar-Chama, Male Infertility Specialist and Urologist at Reproductive Medicine Associates of New York, discusses male infertility testing and treatment options.